|
2013 news from the US Food and Drug Administration.
Click title to see the full article at the FDA
website. For the most up-to-date headlines, check out the FDA
Newsroom. Press announcements from 2004 to 2009 are available through
the FDA
Archive.
English |
español |
December 23, 2013 - FDA
warns consumers not to use muscle growth product |
|
December 23, 2013 - FDA
approves Tretten to treat rare genetic clotting disorder |
|
December 21, 2013 - FDA
announces voluntary nationwide recall of all non-expired sterile drugs
from Abrams Royal Compounding Pharmacy
|
|
December 20, 2013 - FDA
proposes new food defense rule |
|
December 19, 2013 - Montana
dietary supplement maker found in contempt of court |
|
December 18, 2013 - FDA
allows marketing of new stent for treating pseudocysts of the pancreas |
|
December 18, 2013 - FDA
approves Anoro Ellipta to treat chronic obstructive pulmonary disease |
|
December 18, 2013 - FDA
and European Medicines Agency launch generic drug application inspections
initiative |
|
December 16, 2013 - FDA
issues proposed rule to determine safety and effectiveness of antibacterial
soaps |
December 16, 2013 - La
FDA da a conocer su regulación propuesta para determinar la
seguridad y eficacia de los jabones antibacterianos |
December 13, 2013 - FDA
allows marketing of first device to relieve migraine headache pain |
December 13, 2013 - La
FDA permite la comercialización del primer dispositivo para
el alivio de los dolores de cabeza de la migraña |
December 11, 2013 - FDA
approves first generic versions of antidepressant drug Cymbalta |
December 11, 2013 - La
FDA aprueba las primeras versiones genéricas del medicamento
antidepresivo Cymbalta |
December 11, 2013 -
FDA takes significant steps to address antimicrobial resistance |
|
December 06, 2013 - FDA
approves Sovaldi for chronic hepatitis C |
December 06, 2013 - La
FDA aprueba Sovaldi para la hepatitis C crónica |
December 06, 2013 - FDA
approves first drug treatment for Peyronies disease |
December 06, 2013 - La
FDA aprueba el primer medicamento para el tratamiento de la enfermedad
de La Peyronie |
December 04, 2013 - FDA
reaches $1.25 million settlement with Advanced Sterilization Products
and company executives
|
|
December 03, 2013 - FDA
issues safety communication on HeartStart automated external defibrillators
from Philips Healthcare |
|
English |
español |
November 27, 2013 - FDA
study helps provide an understanding of rising rates of whooping cough
and response to vaccination |
|
November 27, 2013 - Court
order keeps food company from production until it cleans up |
|
November 25, 2013 - FDA
requires removal of certain restrictions on the diabetes drug Avandia |
|
November 22, 2013 - FDA
approves new treatment for hepatitis C virus |
November 22, 2013 - La
FDA aprobó nuevo tratamiento para el virus de la hepatitis
C |
November 22, 2013 - FDA
approves first adjuvanted vaccine for prevention of H5N1 avian influenza |
November 22, 2013 - La
FDA aprueba la primera vacuna adyuvante para la prevención
de la gripe aviar H5N1 |
November 22, 2013 - FDA
approves Nexavar to treat type of thyroid cancer |
|
November 19, 2013 - FDA
allows marketing of four next generation gene sequencing
devices |
|
November 18, 2013 - U.S.
Marshals seize more than $2 million in adulterated dietary supplements
from Georgia company
|
|
November 14, 2013 - FDA
approves medical device to treat epilepsy |
November 14, 2013 - La
FDA aprueba dispositivo médico para el tratamiento de la epilepsia |
November 13, 2013 - FDA
approves Imbruvica for rare blood cancer |
|
November 10, 2013 - USPlabs
LLC recalls OxyElite Pro dietary supplements; products linked to liver
illnesses |
|
November 08, 2013 - FDA
approves Aptiom to treat seizures in adults |
November 08, 2013 - La
FDA aprueba el Aptiom para tratar las convulsiones en los adultos |
November 08, 2013 - FDA
approves first generic versions of Aciphex delayed-release tablets
to treat GERD |
November 08, 2013 - La
FDA aprueba las primeras versiones genéricas de los comprimidos
Aciphex de liberación prolongada para tratar la enfermedad
por reflujo gastroesofágico |
November 08, 2013 - FDA
takes action to speed safety information updates on generic drugs
|
|
November 07, 2013 - FDA
takes step to further reduce trans fats in processed foods
|
November 07, 2013 - FDA
toma medidas para reducir aún más las grasas trans en
los alimentos procesados |
November 04, 2013 - FDA:
Janssen Pharmaceuticals, Inc. to plead guilty and pay over $1.6 billion
to resolve allegations of misbranding and filing false claims for
its schizophrenia drug Risperdal |
|
November 01, 2013 - FDA
approves Gazyva for chronic lymphocytic leukemia |
|
English |
español |
October 31, 2013 - FDA
takes two important actions on drug shortages |
|
October 25, 2013 - FDA
approves extended-release, single-entity hydrocodone product
|
|
October 25, 2013 - FDA
approves second brain imaging drug to help evaluate patients for Alzheimers
disease, dementia |
|
October 25, 2013 -
FDA issues proposed rule to help ensure the safety of food for animals
|
|
October 23, 2013 - FDA
to complete phase-out of chlorofluorocarbon inhalers |
October 23, 2013 - La
FDA está por completar la eliminación de los inhaladores
a base de clorofluorocarbono |
October 22, 2013 - FDA
announces voluntary recall of certain sterile products from Specialty
Medicine Compounding Pharmacy
|
|
October 21, 2013 - FDA
takes enforcement action against Oregon dietary supplement manufacturer |
|
October 21, 2013 - FDA
awards 15 grants to stimulate drug, device development for rare diseases |
|
October 18, 2013 - FDA
approves Opsumit to treat pulmonary arterial hypertension
|
|
October 10, 2013 - FDA
approves new pediatric use for Liposorber Apheresis System |
|
October 08, 2013 - FDA
approves Adempas to treat pulmonary hypertension |
|
October 04, 2013 - FDA
approves Clinolipid for intravenous nutrition |
|
|
|